sanofi

Welcome to the 'sanofi' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'sanofi'.

Latest blogosphere posts tagged “sanofi”

• Top Picks for 2010: ImmunoGen (IMGN)

  
  BloggingStocks — Authority: 669
  Filed under: Newsletters , Stocks to Buy , best stocks for 2010 This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nations leading advisors for their single favorite stock for the new year. See all 80 stocks listed here . "Our ...
  2 days ago

• Pharmalot… Pharmalittle… Slowing Down Yet?

  
  Pharmalot — Authority: 546
  A long holiday weekend may be in the offing, but the Pharmalot corporate campus is still humming. And why not? The world has not stopped spinning, after all, and thhere is always something interesting going on. So while you prepare for the holiday or simply slow down the usual pace, here are a few items to help you ...
  3 days ago

• Two charged with insider trading in Chattem deal (Reuters)

  
  Blogger — Authority: 168
  Reuters – Two French citizens have been charged by U.S. regulators with using inside information to buy securities of Chattem Inc before Sanofi-Aventis said it would buy the healthcare group. View original post here:  (Reuters)"> (Reuters)">Two charged with insider trading in Chattem deal ...
  4 days ago

• FluMist Recall, Third H1N1 Swine Flu Vaccine Recall

  
  Ahrcanum "ahR-Kah-noom" > secret secrets — Authority: 127
  RECALLED MedImmune announced it is recalling it’s Nasal Spray vaccine, Flu Mist designed to maybe, prevent Swine Flu.   “Nearly five million doses of an H1N1 swine flu vaccine were recalled today because the strength of the nasal sprays may have decreased over time and they may not be as potent as they ...
  4 days ago

• Michael Aiello: The M.&A. Lawyer Who Doesnt Sleep

  
  DealBook — Authority: 774
  Michael Aiello is on fire. The young mergers and acquisition partner at Weil Gotshal & Manges has had a hand in three high profile public deals for three high profile clients in the last seven days.
  4 days ago

• ($SNY) Sanofi-Aventis Expands Presence in U.S. by Aquiring Chattem

  
  Stock Blog Hub — Authority: 462
  Sanofi-Aventis ( SNY ) has decided to acquire U.S.-based Chattem Inc. ( CHTT ) for $93.50 per share, or approximately $1.9 billion, to create the world’s fifth-largest consumer healthcare company. The offered price represents a 34% premium over Chattem’s Dec. 18th closing price. Currently many pharma players ...
  4 days ago

• A Tactical OTC and Generics Push

  
  PharmTech Talk — Authority: 118
  This week sanofi-aventis agreed to acquire the consumer healthcare company Chattem for $1.9 billion, maker of such products as Selsun Blue haircare products and Gold Bond medicated powders and lotions. In a press release , sanofi says the move is part of its strategy of including consumer healthcare and ...
  5 days ago

• Sanofi-Aventis to buy Chattem

  
  FT Alphaville — Authority: 691
  Sanofi-Aventis, the French pharmaceuticals group, has agreed to buy Chattem, a US consumer healthcare company, in a $1.9bn cash deal that will hasten its diversification away from prescription medicines. Sanofi will pay $93.50 a share for Chattem, pushing Sanofi from the sixth to the world’s fifth largest consumer ...
  5 days ago

• Sanofi-Aventis Buys Chattem for $1.9 Billion

  
  Business Finance & Economy - business.marc8.com — Authority: 165
  The French drug maker Sanofi-Aventis said Monday that it had agreed to buy the consumer health care company Chattem for about $1.9 billion, in a deal which will give Sanofi an over-the-counter presence in the United States.
  5 days ago

• Sanofi-Chattem: Another Bet on the Global Consumer – Wall Street Journal (blog)

  
  Memmis.com News Agency — Authority: 173
  Globe and Mail Sanofi- Chattem : Another Bet on the Global Consumer Wall Street Journal (blog) Sanofi-Aventis $1.9 billion bid for Chattem , the maker of foot power and antidandruff shampoo, signals another large company with a ... Sanofi Boosts Consumer Drugs Portfolio With Chattem Buy ...
  6 days ago

• Sanofi-Aventis Buys Chattem, a Leader in Over-the-Counter Sales

  
  DailyFinance — Authority: 765
  Sanofi-Aventis ( SNY ) announced Monday it will acquire Chattem Inc. ( CHTT ) for about $1.9 billion -- paying $93.50 per share, a 34% premium over Chattems closing price Friday. The deal will create the worlds fifth-largest consumer health-care company by revenues and helps the French drugmaker diversify into ...
  6 days ago

• Sanofi to acquire Chattem of the US for $1.9bn

  
  FT Alphaville — Authority: 691
  Here’s something unseasonal: an M&A announcement coming out of Paris and Chattanooga, Tennessee, days before Xmas. Sanofi-Aventis is paying $1.9bn in cash, or $93.50 per share, for Chattem, a decidedly consumer-facing business which has been producing toiletries, creams and dietary supplements for 130 years....
  6 days ago

• Sanofi-Aventis Buys Chattem, Countering Patent Cliff Losses

  
  Business Pundit — Authority: 606
  Sanofi-Aventis (SAN.FR), one of the world’s largest prescription drug companies by sales, bought Tenn.-based Chattem (CHTT) , which makes products like Gold Bond, Selsun Blue and Icy Hot, for about $1.9 billion in cash (this is $93.50/share). The Wall Street Journal has more : Seeking to offset the impending ...
  6 days ago

• Sanofi Boosts Consumer Drugs Portfolio With Chattem Buy – Wall Street Journal

  
  Memmis.com News Agency — Authority: 173
  Reuters Sanofi Boosts Consumer Drugs Portfolio With Chattem Buy Wall Street Journal FR) Monday stepped up its move into consumer drugs by entering the US market, acquiring Chattem Inc. (CHTT) for $1.9 billion. ... Sanofi to buy Chattem for $1.9 billion in OTC push MarketWatch ...
  6 days ago

• Sanofi-Aventis Buys Chattem for $1.9 Billion

  
  NYT > Theater — Authority: 904
  The deal for the consumer health care group will give Sanofi an over-the-counter presence in the United States.
  6 days ago

• Sanofi-Aventis to Buy Chattem for $1.9 Billion (SNY)

  
  Dividend Stocks - The Dividend Daily — Authority: 494
  French pharmaceutical group Sanofi-Aventis SA ( SNY ) said Monday that it will buy over-the-counter drugmaker Chattem Inc. ( CHTT ) for $1.9 billion. The company will pay $93.50 in cash for each share of Chattem, which represents a 34% premium over the stock’s Friday’s closing price. Chattem, which is ...
  6 days ago

• Sanofi-Aventis Buying Chattem for $1.9 Billion

  
  DealBook — Authority: 774
  Sanofi-Aventis said Monday that it has agreed to acquire Chattem for $1.9 billion in cash, or $93.50 a share.
  6 days ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 546
  Welcome to the working week. We hope your weekend was pleasant, although there was a great deal of shoveling in some parts. Good exercise, yes? Meanwhile, this is a short week for many due to the pending holiday. Nonetheless, this means a flurry of year-end deadlines and meetings. So as you brace yourself for the ...
  6 days ago

• Sanofi Sales Rep Sues For Overtime Pay

  
  Pharmalot — Authority: 546
  Yet another sales rep has joined the battle about overtime pay. The latest involves a Sanofi-Aventis rep in Minnesota, Dede Evavold, who alleges in a putative class action lawsuit ( see here ) that she and others were denied overtime pay in violation of federal law. Typically, sales reps argue they are not exempt from ...
  1 week ago

• (AMLN) Amylin Pharmaceuticals Impresses in Head-to-Head

  
  Stock Blog Hub — Authority: 462
  Amylin Pharmaceuticals, Inc. ( AMLN ) recently announced positive results on its once weekly formulation of Byetta (referred to as exenatide once weekly), which is being developed in collaboration with Eli Lilly and Company ( LLY ) and Alkermes, Inc. ( ALKS ). Amylin presented results from a head-to-head study ...
  1 week ago

Comments about sanofi